{{Rsnum
|rsid=11603334
|Gene=ARAP1
|Chromosome=11
|position=72721940
|Orientation=plus
|GMAF=0.09826
|Gene_s=ARAP1
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(A;A)
|geno2=(A;G)
|geno3=(G;G)
}}{{ population diversity
| geno1=(A;A)
| geno2=(A;G)
| geno3=(G;G)
| CEU | 3.5 | 19.5 | 77.0
| HCB | 0.7 | 16.8 | 82.5
| JPT | 0.0 | 8.0 | 92.0
| YRI | 0.0 | 3.4 | 96.6
| ASW | 0.0 | 8.9 | 91.1
| CHB | 0.7 | 16.8 | 82.5
| CHD | 1.8 | 12.8 | 85.3
| GIH | 5.0 | 37.6 | 57.4
| LWK | 0.0 | 0.9 | 99.1
| MEX | 1.7 | 12.1 | 86.2
| MKK | 0.0 | 9.6 | 90.4
| TSI | 1.0 | 17.6 | 81.4
| HapMapRevision=28
}}{{PMID Auto GWAS
|PMID=21873549
|Trait=None
|Title=Genome-wide association identifies nine common variants associated with fasting proinsulin levels and provides new insights into the pathophysiology of type 2 diabetes.
|RiskAllele=A
|Pval=3E-102
|OR=None
|ORtxt=None
|OA=1
}}

{{PMID Auto GWAS
|PMID=22581228
|Trait=None
|Title=A genome-wide approach accounting for body mass index identifies genetic variants influencing fasting glycemic traits and insulin resistance.
|RiskAllele=
|Pval=2E-14
|OR=None
|ORtxt=None
|OA=1
}}

{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | FTDNA2}}
{{on chip | HumanOmni1Quad}}
{{on chip | Illumina Human 1M}}